Open-Label, Randomized, 3-Arm, Phase 3B Clinical Study to Investigate the Safety and Immunogenicity of a Concomitant Administration of Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate (MenC-TT) Vaccine and 7-Valent Pneumococcal CRM197-Conjugate Vaccine (PCV7) in Toddlers Previously Immunized During Infancy With PCV7

Trial Profile

Open-Label, Randomized, 3-Arm, Phase 3B Clinical Study to Investigate the Safety and Immunogenicity of a Concomitant Administration of Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate (MenC-TT) Vaccine and 7-Valent Pneumococcal CRM197-Conjugate Vaccine (PCV7) in Toddlers Previously Immunized During Infancy With PCV7

Completed
Phase of Trial: Phase III

Latest Information Update: 29 May 2015

At a glance

  • Drugs Meningococcal vaccine group C conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
  • Indications Bacterial meningitis; Pneumococcal infections
  • Focus Pharmacodynamics
  • Sponsors Baxter Healthcare Corporation
  • Most Recent Events

    • 09 Feb 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2007-004276-39).
    • 06 Jan 2010 Actual end date (December 2009) added as reported by ClinicalTrials.gov.
    • 06 Jan 2010 Actual patient number (330) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top